UC researchers to present AI support for Parkinson’s clinicians and medical-record research
The November 19 talks will cover ongoing research, not a validated clinical service. Privacy and patients missing from specialist datasets remain central challenges.
Listen to this story
The audio brief
Story brief
3 key pointsAt the American Parkinson Disease Association’s first AI for Parkinson’s conference on November 19, 2026, University of Cincinnati researchers will present ongoing work on clinician-facing LLM support and extracting longitudinal insights from medical records. One analysis covered more than 25,000 notes from about 2,800 patients over more than a decade, but the work remains research: no clinical benefit or product launch is reported. Broadening the dataset beyond specialist patients, validating extraction, and addressing privacy and computing needs remain key constraints.
- 01
In 2019, fewer than 10% of people with Parkinson’s saw a specialist; those who did waited an average of 90 days.
- 02
Nathaly Chinchihualpa will present a framework combining clinical notes with Cincinnati Cohort Biomarker Program data and receive a Rising Star Award.
- 03
Joaquin Vizcarra plans to discuss AI tools already used in Parkinson’s clinics and technologies that may support future care.
On November 19, 2026, University of Cincinnati researchers Joaquin Vizcarra and Nathaly Chinchihualpa are scheduled to present ongoing AI research in Washington, D.C., at the American Parkinson Disease Association’s first AI for Parkinson’s conference. Their work addresses two connected needs: helping clinicians reach specialist expertise and turning years of medical notes into usable research data.
UC’s announcement does not list a start time, specific venue or watch link.
Starting with the specialist-access gap
UC cites figures showing that fewer than 10% of people with Parkinson’s saw a Parkinson’s specialist in 2019. Those who did waited an average of 90 days for an appointment.
Vizcarra, a research assistant professor and UC Health physician, says the Clinical Intelligence Lab is exploring whether large language models can support clinicians treating patients with limited specialist access.
We’re exploring how to empower primary care physicians, general neurologists or potentially advanced practice providers to have a ‘specialist in their pocket’ with appropriate benchmarks in different levels of care.
Joaquin Vizcarra, University of Cincinnati
Turning clinical histories into research data
Some studies collect data at annual visits, Vizcarra notes, while routine clinical records may hold additional detail about symptoms and treatment between those visits. Organizing that information could complement formal research measurements.
Large language models can help extract information from free-form clinical notes and organize it into structured data, Vizcarra says, with careful accuracy checks. In one study, he says, the team analyzed more than 25,000 notes from approximately 2,800 patients, covering more than a decade of follow-up.
The potential value includes observations such as a doctor noting emerging memory problems. The researchers hope organizing such details over time could reveal earlier signals and help characterize Parkinson’s subtypes. Those are research possibilities, not demonstrated improvements in patient care.
There is also a gap in whose histories the lab can study. It is working to broaden its dataset beyond patients who see specialists, so the records better represent the wider Parkinson’s population.
What the team will bring to Washington
Privacy, data governance and computing capacity remain active challenges, Vizcarra says. The team is working on protections for patient information and the computing resources needed to extend its work beyond a single clinic across the health system.
At the conference, Vizcarra plans to survey AI tools currently used in Parkinson’s clinics and technologies that may support future care. Chinchihualpa, a UC neurology research fellow, will give a lightning presentation on a framework combining clinical notes with data from the Cincinnati Cohort Biomarker Program. The goal is detailed research data tracking how the disease evolves in individual patients.
Chinchihualpa will also receive a Rising Star Award. The November 19 presentations are a forum for this ongoing work, rather than the launch of a new clinical product.
Sources
- uc.eduUC experts head to Washington, D.C., to discuss AI applications in Parkinson’s care, research
Reader comments
Newest comments first. Replies stay oldest first.